• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Hemodynamic determinants of exercise-induced abnormal blood pressure response in hypertrophic cardiomyopathy.

作者信息

Ciampi Quirino, Betocchi Sandro, Lombardi Raffaella, Manganelli Fiore, Storto Giovanni, Losi Maria Angela, Pezzella Elpidio, Finizio Filippo, Cuocolo Alberto, Chiariello Massimo

机构信息

Department of Clinical Medicine, Cardiovascular and Immunological Sciences, Federico II University School of Medicine, Via S. Pansini 5, Naples, I-80131 Italy.

出版信息

J Am Coll Cardiol. 2002 Jul 17;40(2):278-84. doi: 10.1016/s0735-1097(02)01950-2.

DOI:10.1016/s0735-1097(02)01950-2
PMID:12106932
Abstract

OBJECTIVES

We sought to assess the hemodynamics of exercise in patients with hypertrophic cardiomyopathy (HCM), with and without an exercise-induced abnormal blood pressure (BP) response, by ambulatory radionuclide monitoring of left ventricular (LV) function with the VEST device (Capintec Inc., Ramsey, New Jersey).

BACKGROUND

Blood pressure fails to increase >20 mm Hg during exercise in about one-third of patients with HCM. This carries a high risk of sudden death.

METHODS

Forty-three patients with HCM and 14 control subjects underwent maximal symptom-limited exercise on a treadmill during VEST. The VEST data were averaged for 1 min and analyzed at baseline, 3 min and peak exercise. The LV end-diastolic, end-systolic and stroke volumes, cardiac output and systemic vascular resistance were expressed as the percentage of baseline.

RESULTS

Ejection fraction and stroke volume fell in patients with HCM, although they increased in control subjects (p < 0.001 and p = 0.002, respectively). Cardiac output increased significantly more in control subjects than in patients with HCM (p = 0.001). In 17 patients with HCM (39%) with an abnormal BP response, ejection fraction and stroke volume fell more (p = 0.032 and p = 0.009, respectively) and cardiac output increased less (p = 0.001) than they did in patients with HCM with a normal BP response. Systemic vascular resistance decreased similarly in patients with HCM, irrespective of the BP response.

CONCLUSIONS

In patients with HCM with and without an abnormal BP response, abnormal hemodynamic adaptation to exercise was qualitatively similar but quantitatively different. An abnormal BP response was associated with exercise-induced LV systolic dysfunction. This causes hemodynamic instability, associated with a high risk of sudden cardiac death.

摘要

相似文献

1
Hemodynamic determinants of exercise-induced abnormal blood pressure response in hypertrophic cardiomyopathy.
J Am Coll Cardiol. 2002 Jul 17;40(2):278-84. doi: 10.1016/s0735-1097(02)01950-2.
2
Abnormal blood-pressure response to exercise and oxygen consumption in patients with hypertrophic cardiomyopathy.
J Nucl Cardiol. 2007 Nov-Dec;14(6):869-75. doi: 10.1016/j.nuclcard.2007.08.003. Epub 2007 Oct 22.
3
Hemodynamic effects of isometric exercise in hypertrophic cardiomyopathy: comparison with normal subjects.肥厚型心肌病患者等长运动的血流动力学效应:与正常受试者的比较。
J Nucl Cardiol. 2003 Mar-Apr;10(2):154-60. doi: 10.1067/mnc.2003.9.
4
Exercise capacity in hypertrophic cardiomyopathy. Role of stroke volume limitation, heart rate, and diastolic filling characteristics.肥厚型心肌病的运动能力。每搏输出量限制、心率及舒张期充盈特征的作用。
Circulation. 1995 Nov 15;92(10):2886-94. doi: 10.1161/01.cir.92.10.2886.
5
[Left ventricular function at rest and during exercise and the effects of propranolol in patients with hypertrophic cardiomyopathy].[肥厚型心肌病患者静息及运动时的左心室功能及普萘洛尔的影响]
J Cardiol Suppl. 1987;16:35-51.
6
Hemodynamic changes and prognosis in patients with hypertrophic cardiomyopathy and abnormal blood pressure responses during exercise.肥厚型心肌病患者运动期间血压反应异常的血流动力学变化及预后
Clin Cardiol. 2003 Feb;26(2):71-6. doi: 10.1002/clc.4960260206.
7
Systolic function reserve using two-dimensional strain imaging in hypertrophic cardiomyopathy: comparison with essential hypertension.二维应变成像技术评估肥厚型心肌病与原发性高血压患者左室收缩功能储备的对比研究。
J Am Soc Echocardiogr. 2013 Dec;26(12):1397-406. doi: 10.1016/j.echo.2013.08.026. Epub 2013 Oct 3.
8
Assessment of left ventricular systolic and diastolic abnormalities in patients with hypertrophic cardiomyopathy using real-time three-dimensional echocardiography and two-dimensional speckle tracking imaging.使用实时三维超声心动图和二维斑点追踪成像评估肥厚型心肌病患者的左心室收缩和舒张异常。
Cardiovasc Ultrasound. 2018 Oct 2;16(1):23. doi: 10.1186/s12947-018-0142-y.
9
[Left ventricular function in hypertrophic cardiomyopathy: a Tc-99m radionuclide angiographic study during exercise].肥厚型心肌病的左心室功能:运动期间的Tc-99m放射性核素血管造影研究
J Cardiogr Suppl. 1986(8):63-73.
10
Abnormal vascular responses to supine exercise in hypertrophic cardiomyopathy.
Circulation. 1991 Aug;84(2):686-96. doi: 10.1161/01.cir.84.2.686.

引用本文的文献

1
Incidence of cardiovascular risk factors and exercise phenotyping in cardiomyopathies: One size does not fit all.心肌病中心血管危险因素的发生率及运动表型分析:并非一概而论。
Int J Cardiol Heart Vasc. 2025 Jun 17;59:101722. doi: 10.1016/j.ijcha.2025.101722. eCollection 2025 Aug.
2
Mexican guidelines 2024 for the diagnosis and treatment of hypertrophic cardiomyopathy.《2024年墨西哥肥厚型心肌病诊断与治疗指南》
Arch Cardiol Mex. 2024;94(Supl 4):1-75. doi: 10.24875/ACM.M25000098.
3
JCS/JHRS 2022 Guideline on Diagnosis and Risk Assessment of Arrhythmia.
《日本循环学会/日本心律学会2022年心律失常诊断与风险评估指南》
J Arrhythm. 2024 Jun 12;40(4):655-752. doi: 10.1002/joa3.13052. eCollection 2024 Aug.
4
Role of cardiovascular magnetic resonance imaging and cardiopulmonary exercise test in predicting composite clinical outcomes in patients with hypertrophic cardiomyopathy.心血管磁共振成像和心肺运动试验在预测肥厚型心肌病患者复合临床结局中的作用。
PLoS One. 2023 May 16;18(5):e0285887. doi: 10.1371/journal.pone.0285887. eCollection 2023.
5
Hypertrophic Cardiomyopathy: Updates Through the Lens of Sports Cardiology.肥厚型心肌病:从运动心脏病学视角的更新
Curr Treat Options Cardiovasc Med. 2021;23(8):53. doi: 10.1007/s11936-021-00934-1. Epub 2021 May 25.
6
Genotype-Related Clinical Characteristics and Myocardial Fibrosis and their Association with Prognosis in Hypertrophic Cardiomyopathy.肥厚型心肌病的基因型相关临床特征、心肌纤维化及其与预后的关系
J Clin Med. 2020 Jun 1;9(6):1671. doi: 10.3390/jcm9061671.
7
Risk Stratification in Hypertrophic Cardiomyopathy. Insights from Genetic Analysis and Cardiopulmonary Exercise Testing.肥厚型心肌病的风险分层。来自基因分析和心肺运动试验的见解。
J Clin Med. 2020 May 28;9(6):1636. doi: 10.3390/jcm9061636.
8
Exercise and hypertrophic cardiomyopathy: Two incompatible entities?运动与肥厚型心肌病:二者是否水火不容?
Clin Cardiol. 2020 Aug;43(8):889-896. doi: 10.1002/clc.23343. Epub 2020 Feb 12.
9
Risk Stratification in Hypertrophic Cardiomyopathy.肥厚型心肌病的风险分层
Eur Cardiol. 2015 Jul;10(1):31-36. doi: 10.15420/ecr.2015.10.01.31.
10
Risk stratification in hypertrophic cardiomyopathy.肥厚型心肌病的风险分层
Herz. 2020 Feb;45(1):50-64. doi: 10.1007/s00059-018-4700-8. Epub 2018 Apr 25.